Angene Chemical
Draw
|
Currency :
Home Products

AG0048C1

88321-09-9 | 2-Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, ethyl ester, (2S,3S)-

Chemical structure of 2-Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, ethyl ester, (2S,3S)-, CAS 88321-09-9
AG0048C1
sdsSDS
sdsCOA

Price

$0.00

Add to Cart
WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 88321-09-9
Catalog Number AG0048C1(AGN-PC-0VKP19)
Chemical Name 2-Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, ethyl ester, (2S,3S)-
IUPAC Name ethyl (2S,3S)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate
InChI InChI=1S/C17H30N2O5/c1-6-23-17(22)14-13(24-14)16(21)19-12(9-11(4)5)15(20)18-8-7-10(2)3/h10-14H,6-9H2,1-5H3,(H,18,20)(H,19,21)/t12-,13-,14-/m0/s1
InChI Key SRVFFFJZQVENJC-IHRRRGAJSA-N
MDL Number MFCD00132883
Molecular Formula C17H30N2O5
Molecular Weight 342.4305
SMILES O=C([C@H]1O[C@@H]1C(N[C@@H](CC(C)C)C(NCCC(C)C)=O)=O)OCC
UNII L5W337AOUR
Synonyms
(2S,3S)-trans-epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester, aloxistatin, E64d inhibitor, EP 453, EP-453, epoxysuccinyl-leucylamide(3-methyl)butane ethyl ester, ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate, ethyl 3-(3-methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylate, ethyl epoxysuccinyl-leucylamido-3-methylbutane, loxistatin, loxistatin, (2S-(2alpha,3beta(R*)))-isomer, protease inhibitor E64d, Aloxistatin, 88321-09-9, E-64D, Loxistatin, E 64d, Aloxistatina, Aloxistatine, Aloxistatinum, Aloxistatin [INN], E 64c ethyl ester, EST (pharmaceutical), Aloxistatine [French], Aloxistatinum [Latin], Aloxistatina [Spanish], UNII-L5W337AOUR, CCRIS 1934, EST, C17H30N2O5, EP 453, E64d, NSC 694281, BRN 5354546, L5W337AOUR, CHEMBL63440, MLS000028372, MFCD00132883, SMR000058552, (2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester, Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate, (2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]-butyl]amino]carbonyl]-2-oxiranecarboxylic acid ethyl ester, (2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-2-oxiranecarboxylic acid ethyl ester, ethyl (2S,3S)-3-[[(2S)-4-methyl-1-(3-methylbutylamino)-1-oxopentan-2-yl]carbamoyl]oxirane-2-carboxylate, Oxiranecarboxylic acid, 3-((((1S)-3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)-, ethyl ester, (2S,3S)-, Oxiranecarboxylic acid, 3-(((3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)-, ethyl ester, (2S-(2-alpha,3-beta(R*)))-, E-64-d, estat, NSC694281, E64c ethyl ester, Aloxistatin(E64d), E-64d(Aloxistatin), Opera_ID_506, E-64d protease inhibitor, AC1L23PT, E-64d, protease inhibitor, CBiol_001881, MLS006010826, SCHEMBL483320, EX-A860, CHEBI:101381, SRVFFFJZQVENJC-IHRRRGAJSA-N, Bio1_000167, Bio1_000656, Bio1_001145, HMS2236F06, HMS3403C21, ZINC3913912, BDBM50052693, s7393, AKOS024458215, CCG-207846, CS-5996, E-64d(Aloxistatin,Loxistatin pound(c), NCGC00167328-03, QC-10414, HY-100229, LS-101008, X6849, A13259, (2S-(2alpha,3beta(R*)))-isomer of loxistatin, SR-01000759197, SR-01000759197-2, BRD-K91188791-001-12-6, BRD-K91188791-001-18-3, (2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester EST, (2S,3S)-trans-Epoxysuccinyl-L-leucylamido-3-methylbutane ethyl ester,, (2S,3S)-3-[(S)-3-Methyl-1-(3-methyl-butylcarbamoyl)-butylcarbamoyl]-oxirane-2-carboxylic acid ethyl ester, (2S,3S)-ethyl 3-(((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxylate, (2S,3S)-ethyl 3-((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-ylcarbamoyl)oxirane-2-carboxylate, 3-[[[(1S)-3-Methyl-1[[(3S-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-2S-oxiranecarboxylic acid, ethyl ester, 3-[3-Methyl-1-(3-methyl-butylcarbamoyl)-butylcarbamoyl]-oxirane-2-carboxylic acid ethyl ester, ethyl (2S,3S)-3-(((S)-1-(isopentylamino)-4-methyl-1-oxopentan-2-yl)carbamoyl)oxirane-2-carboxyla, ethyl (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylate, ethyl (2S,3S)-3-[[(1S)-1-(isopentylcarbamoyl)-3-methyl-butyl]carbamoyl]oxirane-2-carboxylate, trans-Ethyl (+)-(2S,3S)-2,3-epoxy-N-((S)-1-(isopentylcarbamoyl)-3-methylbutyl)succinamate, Estate, D0NJ1A, CID65663, C17-H30-N2-O5, ACN-053684, A1903, Aloxistatin, 98%, irreversible cell-permeable cysteine protease inhibitor - 1MG 1mg, TE,

Related Research Chemicals

    CERTIFICATE OF ANALYSIS
    Chemical Name: Batch Number:
    Chemical Structure: CAS Registry No:
    		Product ID:
    Manufacture Date:
    Storage Temperature:
    Formula:
    Molecular Weight:
    Quantity:
    Analysis Data:
    Test: Result:
    Conclusion: The above product meets the specifications of Angene.
    Analyst:Chase
    Date:
    Reviewed by:Jessie
    Date:
    Angene International Limited